+ Main Category
+ Tell a Friend
Fill out the information below to email a friend a brief note about 'Pomology: Fruit Cultivation and Production'
+ Top 10
+ Directory Statistics
Links: 1182
Categories: 54
Registered Users: 178
Mailing List Subscribers: 24
+ Pagerank Statistics
+ Join Mailing List
Joining mailing list will entitle you to receive occasional emails informing you of news and updates to the site and any special offers that may be of interest to you.
Research > Chapter 10015
Bookmarks
Interleukin-1beta interleukin-1 receptor antagonist act striatum modify excitotoxic brain damage rat.
Interleukin-1beta thiobarbituric acid reactive agent (TBARS) levels phase I periodontal therapy patients chronic periodontitis.
Interleukin-1beta tumor necrosis factor-alpha children major depressive disorder dysthymia.
Interleukin-1beta tumor necrosis factor-alpha suppress dexamethasone induction glutamine synthetase primary mouse astrocytes.
Interleukin-1beta tumor necrosis factor-alpha upregulate interleukin-23 subunit p19 gene expression human colonic subepithelial myofibroblasts.
Interleukin-1beta tumor necrosis factor-alpha, interleukin-6, induce osteoprotegerin ligand gene expression human osteoblastic cells.
Interleukin-1beta tumour necrosis factor-alpha promote transformation human immortalised mesothelial cells erionite.
Interleukin-1beta marker mucosal injury inflammation.
Interleukin-1beta attenuates endothelin B receptor-mediated airway contractions murine vitro model asthma - roles endothelin converting enzyme mitogen-activated protein kinase pathways.
Interleukin-1beta augments vitro alveolar epithelial repair.
Interleukin-1beta cytokines abrogates tolerance contact allergen.
Interleukin-1beta tumor necrosis factor involved in Nile Virus-induced Langerhans cell migration skin C57BL/6 mice.
Interleukin-1beta mediate growth arrest differentiation leukemia inhibitory factor/JAK/STAT pathway medullary thyroid carcinoma cells.
Interleukin-1beta biphasic answer neurons rat major pelvic ganglia.
Interleukin-1beta diverse levels nitric oxide-mediated depression contractility diverse positions rat thoracic aorta.
Interleukin-1beta contributes generation experimental febrile seizures.
Interleukin-1beta converting enzyme (caspase-1) intestinal inflammation.
Interleukin-1beta converting enzyme subfamily inhibitors prevent induction CD86 molecules butyrate CREB-dependent mechanism HL60 cells.
Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) soluble APO-1/Fas/CD 95 receptor amyotrophic lateral sclerosis patients.
Interleukin-1beta costimulates interferon-gamma production human natural killer cells.
Interleukin-1beta insufficiency results reduced NF-kappaB levels pregnant mice.
Interleukin-1beta depolarizes paraventricular nucleus parvocellular neurones.
Interleukin-1beta contribute genetic strain-based differences iNOS expression activity chicken macrophages.
Interleukin-1beta down-regulates expression glucuronosyltransferase I key enzyme priming glycosaminoglycan biosynthesis - Effect glucosamine interleukin-1beta-mediated effects rat chondrocytes.
Interleukin-1beta down-regulates oxytocin receptor cultured uterine smooth muscle cells.
Interleukin-1beta altitude postpartum period.
Interleukin-1beta enhances interferon-gamma suppresses activin A actions reciprocally regulating activin A follistatin secretion bone marrow stromal fibroblasts.
Interleukin-1beta enhances non-rapid eye movement sleep microinjected dorsal raphe nucleus inhibits serotonergic neurons vitro.
Interleukin-1beta enhances retinoic acid-mediated expression bone-type alkaline phosphatase rat IEC-6 cells.
Interleukin-1beta exacerbates hypoxia-induced neuronal damage, attenuates toxicity produced simulated ischaemia excitotoxicity rat organotypic hippocampal slice cultures.
Interleukin-1beta expression phospholipase A2 activation intestinal ischemia/reperfusion injury.
Interleukin-1beta expression pineal gland rat.
Interleukin-1beta fever rats - Gender difference estrous cycle effect.
Interleukin-1beta folding pH 5 7 - Experimental proof three-state folding behavior robust transition condition positions late folding.
Interleukin-1beta fragment (163-171) modulates bovine granulosa cell proliferation vitro - Dependence size follicle.
Interleukin-1beta gene polymorphisms hepatocellular carcinoma hepatitis C virus infection.
Interleukin-1beta gene transcription U937 cells modulated type I collagen cytoskeletal integrity distinct signaling pathways.
Interleukin-1beta genetic polymorphism influences influence cytochrome P 2C19 genotype thetreatment rate 1-week triple therapy Helicobacter pylori infection.
Interleukin-1beta function cerebral cortical state-dependent electroencephalographic slow-wave activity.
Interleukin-1beta immunoreactivity identified neurons rat magnocellular neurosecretory scheme - Proof activity-dependent release.
Interleukin-1beta antigen-induced arthritis rabbit temporomandibular joint.
Interleukin-1beta plasma synovial fluid relationship radiographic arthritic temporomandibular joints.
Interleukin-1beta functional structural luteolysis. Relationship nitric oxide scheme.
Interleukin-1beta hypothalamus potentiates feline defensive rage - Role serotonin-2 receptors.
Interleukin-1beta increases RANTES gene expression production synovial fibroblasts human temporomandibular joint.
Interleukin-1beta increases binding iron regulatory protein synthesis ferritin increasing labile iron pool.
Interleukin-1beta increases spinal cord wind-up activity normal monoarthritic rats.
Interleukin-1beta increases Bcl-2/Bax ratio Kaposi's sarcoma cells.
Interleukin-1beta increases functional expression connexin 43 articular chondrocytes - Proof Ca2+-dependent mechanism.
Interleukin-1beta increases urine flow rate inhibits protein expression Na+/K+-ATPase rat jejunum kidney.
Interleukin-1beta stimulated protein expression rat islets. computerized database.
Interleukin-1beta stimulated cyclooxygenase 2 expression prostaglandin E2 secretion human neuroblastoma cells - Implications Alzheimer's disease.
Interleukin-1beta stimulated synthesis protein kinase C-delta protein kinase C-epsilon EL4 thymoma cells - Possible involvement phosphatidylinositol 3-kinase.
Interleukin-1beta induces MUC2 gene expression mucin secretion activation PKC-MEK/ERK, PI3K human airway epithelial cells.
Interleukin-1beta induces apoptosis GL15 glioblastoma-derived human cell line.
Interleukin-1beta induces cyclo-oxygenase-2 expression gastric cancer cells p38 p44/42 mitogen-activated protein kinase signaling pathways.
Interleukin-1beta induces cyclooxygenase-2 prostaglandin E2 synthesis human neuroblastoma cells - Involvement p38 mitogen-activated protein kinase nuclear factor-kappaB.
Interleukin-1beta induces diverse gene expression stromelysin, aggrecan tumor-necrosis-factor-stimulated gene 6 human osteoarthritic chondrocytes vitro.
Interleukin-1beta induces altitude spermidine/spermine N1-acetyltransferase activity increase amount putrescine synovial adherent cells patients rheumatoid arthritis.
Interleukin-1beta induces expression neuropeptide Y primary astrocyte cultures cytokine-specific manner - Induction human rat astrocytes.
Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression fibronectin production.
Interleukin-1beta induces vivo tolerance lipopolysaccharide mice.
Interleukin-1beta induces interleukin-6 mRNA expression protein production synovial cells human temporomandibular joint.
Interleukin-1beta induces interleukin-6 production production prostaglandin E2 human osteoblasts, MG-63 cells.
Interleukin-1beta induces macrophage inflammatory protein-beta expression human hepatocytes.
Interleukin-1beta induces ornithine decarboxylase activity insulin-producing cells.
Interleukin-1beta induces agent P release primary afferent neurons cyclooxygenase-2 scheme.
Interleukin-1beta induces expression lipocortin 1 mRNA cultured rat cortical astrocytes.
Interleukin-1beta induction c-fos collagenase expression articular chondrocytes - Involvement reactive oxygen species.
Interleukin-1beta induction chemokine RANTES promoter human astrocytoma line CH235 requires constitutive inducible transcription factors.
Interleukin-1beta inhibits ATP-induced protein kinase B activation renal mesangial cells diverse mechanisms - The involvement nitric oxide ceramide.
Interleukin-1beta inhibits PDGF-BB-induced migration cooperating PDGF-BB stimulate cyclooxygenase-2 expression baboon aortic smooth muscle cells.
Interleukin-1beta inhibits tetraethylammonium-induced synaptic potentiation rat dentate gyrus vitro.
Interleukin-1beta inhibits vitro pulsatile progesterone secretion stimulates prostaglandin F2alpha secretion micro-retrodialyzed baboon corpus luteum.
Interleukin-1beta inhibits phospholipase C insulin secretion sites KATP channel.
Interleukin-1beta inhibits proinsulin conversion rat beta-cells nitric oxide-dependent pathway.
Interleukin-1beta injected intracisternally inhibited NMDA-evoked behavioral answer orofacial region freely moving rats.
Interleukin-1beta is involved in the pressor response of amygdaloid neurons excited by sodium glutamate.
Interleukin-1beta required early evolution reactive astrogliosis CNS lesion.
Interleukin-1beta extracted marine fish reveals up-regulated expression macrophages activation lipopolysaccharide lymphokines.
Interleukin-1beta degree gingival crevicular fluid patients active periodontitis.
Interleukin-1beta maintains apoptosis-resistant phenotype blast cells acute myeloid leukaemia multiple pathways.
Interleukin-1beta mediates ischemic injury rat retina.
Interleukin-1beta mediates memory impairment delayed type hypersensitivity answer bacillus Calmette-Guerin rat hippocampus.
Interleukin-1beta messenger ribonucleic acid protein levels fluid-percussion brain injury rats - Importance injury severity brain temperature.
Interleukin-1beta modulates state-dependent discharge activity preoptic region basal forebrain neurons - function sleep regulation.
Interleukin-1beta partially alleviates cyclosporin A-induced suppression IgG1 isotype answer thyroglobulin BALB/c mice vivo.
Interleukin-1beta polymorphisms Colombian patients autoimmune rheumatic diseases.
Interleukin-1beta posttranslational processing - Exploration P2X7 receptor involvement.
Interleukin-1beta potentiates endothelin ETB receptor-mediated contraction cultured segments human temporal artery.
Interleukin-1beta production dysthymia pharmacotherapy.
Interleukin-1beta promotes oligodendrocyte death glutamate excitotoxicity.
Interleukin-1beta protects neurons interleukin-1 (IL-1) receptor-mediated Akt pathway IL-1 receptor-independent decrease transmembrane currents vivo.
Interleukin-1beta reduces temperature sensitivity elevates thermal thresholds diverse populations warm-sensitive hypothalamic neurons rat brain slices.
Interleukin-1beta regulates CFTR expression human intestinal T84 cells.
Interleukin-1beta regulation adhesion molecules human gingival periodontal ligament fibroblasts.
Interleukin-1beta regulation gonadotropin-releasing hormone messenger ribonucleic acid cultured human endometrial stromal cells.
Interleukin-1beta represses MRP2 gene expression inactivation interferon regulatory factor 3 HepG2 cells.
Interleukin-1beta responses Mycoplasma pneumoniae infection cell-type special.
Interleukin-1beta stimulates IL-8 expression MAP kinase ROS signaling human gastric carcinoma cells.
Interleukin-1beta stimulates cyclic GMP efflux brain astrocytes.
Interleukin-1beta stimulates galectin-9 expression in human astrocytes.
Interleukin-1beta stimulates growth hormone-releasing hormone receptor mRNA expression rat hypothalamus vitro vivo.
Interleukin-1beta stimulates human renal fibroblast proliferation matrix protein production measure transforming growth factor-beta-dependent mechanism.
Interleukin-1beta stimulates macrophage inflammatory protein-1alpha -1beta expression human neuronal cells (NT2-N).
Interleukin-1beta stimulates matrix metalloproteinase-2 expression prostaglandin E2-dependent mechanism human chondrocytes.
Interleukin-1beta stimulates transendothelial mobilization human peripheral blood mononuclear cells potential differentiate osteoclasts presence osteoblasts.
Interleukin-1beta suppresses growth hormone-induced acid-labile subunit mRNA levels secretion primary hepatocytes.
Interleukin-1beta swiftly down-regulates UCP-2 mRNA beta-cells mechanisms coupled toxicity.
Interleukin-1beta switches electrophysiological states synovial fibroblasts.
Interleukin-1beta scheme (ligand, receptor type I, receptor accessory protein receptor antagonist), TNF-alpha, TGF-beta1 neuropeptide Y mRNAs special brain regions bacterial LPS-induced anorexia.
Interleukin-1beta tear concentration glaucomatous ocular hypertensive patients treated preservative-free nonselective beta-blockers.
Interleukin-1beta up-regulates expression neurofilament light human neuronal cells.
Interleukin-1beta up-regulates iron efflux rat C6 glioma cells modulation ceruloplasmin ferroportin-1 synthesis.
Interleukin-1beta up-regulates nitrite production - effects ovarian role.
Interleukin-1beta up-regulates expression thrombopoietin transcription factors c-Jun, c-Fos, GATA-1, NF-E2 megakaryocytic cells.
Interleukin-1beta upregulates MMP-9 expression stromal cells human giant cell tumor bone.
Interleukin-1beta upregulates cardiac expression vascular endothelial growth factor receptor KDR/flk-1 activation protein tyrosine kinases.
Interleukin-1beta, -6 interferon-gamma productions patients undergoing continuous ambulatory peritoneal dialysis.
Interleukin-1beta, -6, -12 tumor necrosis factor-alpha expression brains dogs canine distemper virus infection.
Interleukin-1beta, Src- non-Src tyrosine kinases, nitric oxide synthase induction rat aorta vitro.
Interleukin-1beta, IL-1alpha, mediates nerve growth factor secretion rat astrocytes type I IL-1 receptor.
Interleukin-1beta, interleukin-1alpha, required T-cell-dependent antibody production.
Interleukin-1beta, medical parameters matched cellular-histopathologic biopsied gingival tissue periodontitis patients.
Interleukin-1beta, inducible nitric oxide synthase, nuclear factor-kappaB stimulated morphologically distinct microglia rat hippocampal lipopolysaccharide/interferon-gamma injection.
Interleukin-1beta, interleukin-1 receptor antagonist levels patients subacute sclerosing panencephalitis effects diverse cure protocols.
Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, interleukin-10 gene polymorphisms - Relationship incidence severity rheumatoid arthritis.
Interleukin-1beta, interleukin-6, tumour necrosis factor-alpha interferon-gamma released viral infection aseptic inflammation reduce CYP1A1, 1A2 3A6 expression rabbit hepatocytes.
Interleukin-1beta, tumor necrosis factor-alpha, nitrite levels febrile seizures.
Interleukin-1beta-converting enzyme-lacking mice resist systemic endotoxin-induced anorexia.
Interleukin-1beta-converting enzyme/caspase-1 human osteoarthritic tissues - Localization function maturation interleukin-1beta interleukin-18.
Interleukin-1beta-dependent hippocampus parenteral immunization cell pertussis vaccine.
Interleukin-1beta-induced airway hyperresponsiveness enhances agent P intrinsic neurons ferret airway.
Interleukin-1beta-induced cyclooxygenase-2 expression mediated activation p42/44 p38 MAPKS, NF-kappaB pathways canine tracheal smooth muscle cells.
Interleukin-1beta-induced expression IL-6 production human chorionic gonadotropin human trophoblast cells nuclear factor-kappaB activation.
Interleukin-1beta-induced expression urokinase-type plasminogen activator receptor co-localization MMPs human articular chondrocytes.
Interleukin-1beta-induced fever young Long-Evans rats.
Interleukin-1beta-induced hyperresponsiveness (Sar9,Met(O2)11)substance P extracted human bronchi.
Interleukin-1beta-induced increases plasma catecholamine levels rats - Enhancement superior cervical ganglionectomy.
Interleukin-1beta-induced nitric oxide production inhibition insulin secretion rat islets Langerhans dependent nitric oxide synthase cofactor tetrahydrobiopterin.
Interleukin-1beta-induced nitric oxide production rat aortic endothelial cells - Inhibition estradiol normal high glucose cultures.
Interleukin-1beta-induced nitric oxide production rat aortic endothelial cells - inhibition estradiol normal high glucose cultures.
Interleukin-1beta-induced promatrilysin expression mediated NFkappaB-regulated synthesis interleukin-6 prostate carcinoma cell line, LNCaP.
Interleukin-1beta-induced prostaglandin E2 production human myometrial cells - Role pertussis toxin-sensitive constituent.
Interleukin-1beta-induced agent P release rat cultured primary afferent neurons driven phospholipase A2 enzymes - Secretory type IIA cytosolic type IV.
Interleukin-1beta-induced type IIA secreted phospholipase A2 gene expression extracellular activity rat vascular endothelial cells.
Interleukin-1beta-mediated induction Cox-2 CNS contributes inflammatory pain hypersensitivity.
Interleukin-2.
Interleukin-2 (IL-2) activated natural killer (A-NK) cells - Binding microvascular endothelial cells BRM enhancement cytolytic activity.
Interleukin-2 (IL-2) IL-6 regulate c-fos protooncogene expression human pituitary adenoma explants.
Interleukin-2 (IL-2) interleukin-2 receptor (IL-2R) normals disorders.
Interleukin-2 (IL-2) expression livers patients chronic hepatitis C virus (HCV) infection.
Interleukin-2 (IL-2) gene therapy allogeneic fibroblasts CT-26 model murine colorectal carcinoma.
Interleukin-2 (IL-2) induces erythroid differentiation tyrosine phosphorylation ELM-I-1 cells transfected human IL-2 receptor beta chain cDNA.
Interleukin-2 (IL-2) production human B-cell line.
Interleukin-2 (IL-2) recepter-betagamma signalling activated c-Kit absence IL-2, exogenous IL-2 JAK3/STAT5 human papillomavirus-associated cervical cancer.
Interleukin-2 (IL-2) receptor alpha, beta gamma subunit expression role B-cell lineage ontogeny - The IL-2-PE66-4Glu characterize internalization IL-2 receptor subunits.
Interleukin-2 (IL-2) receptor levels patients visceral leishmaniosis Turkey.
Interleukin-2 (Il-2) receptor gamma chain mutations X-linked severe combined immunoinsufficiency disease finding loss high-affinity IL-2 receptor binding.
Interleukin-2 Pseudomonas exotoxin chimeric protein cytotoxic B cell cultures derived myasthenia gravis patients.
Interleukin-2 Receptor Expression Salivary Glands Patients Sjogren's Syndrome.
Interleukin-2 abolishes myeloid cell accumulation stimulated Lewis lung carcinoma.
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: The ILSTIM study - ANRS 082.
Interleukin-2 activated NK cells CD95L- TRAIL-pathways fast induction apoptosis rat colon carcinoma CC531s cells.
Interleukin-2 activated lymphocytes show good sensitivity class 1 HLA typing.
Interleukin-2 activated microglia engulf tumor infiltrating T cells the nervous scheme.
Interleukin-2 activates sub-population cutaneous C-fibre polymodal nociceptors rat hairy skin.
Interleukin-2 activates human peripheral blood eosinophils.
Interleukin-2 activation chemotherapy growth factor-mobilized peripheral blood stem cells generation cytotoxic effectors.
Interleukin-2 activation cytotoxic cells postmastectomy seroma.
Interleukin-2 activation haematopoietic stem cells.
Interleukin-2 activation human bone marrow long-term cultures - An effective strategy purging generation anti-tumor cytotoxic effectors.
Interleukin-2 activity chronic HBV-infection - Association viral replication.
Interleukin-2 activity patients extensive small-cell lung cancer. phase II experiment cancer leukemia group B.
Interleukin-2 activity colonic lamina propria mononuclear cells rat model experimental colitis.
Interleukin-2 administration alters CD4(+)FOXP3(+) T-cell pool tumor trafficking patients ovarian carcinoma.
Interleukin-2 affects cochlear role gradually reversibly.
Interleukin-2 affects steroidogenesis numbers bovine ovarian granulosa cells thecal cells vitro.
Interleukin-2 affects steroidogenesis bovine ovarian granulosa cells thecal cells vitro.
Interleukin-2 autologous stem cell transplantation hematologic malignancy. phase I/II study.
Interleukin-2 alters positions capillary venule pericytes rat cremaster muscle.
Interleukin-2 -4 stimulate resistance granulocyte-macrophage colony-stimulating factor corticosteroids.
Interleukin-2 -6 stimulate behavioral-activating effects mice.
Interleukin-2 13-cis retinoic acid maintenance therapy advanced ovarian cancer.
Interleukin-2 13-cis retinoic acid cure minimal residual disease. phase II study.
Interleukin-2 allogeneic LAK cell therapy patient acute myeloid leukemia.
Interleukin-2 cancer - Critical examination results, problems expectations.
Interleukin-2 dendritic cells adjuvants surgical therapy tumours human papillomavirus type 16.
Interleukin-2 granulocyte-macrophage colony stimulating factor alternative donor lymphocyte infusion relapse allogeneic stem cell transplantation increase immune effector cells polarization type 2 dendritic cells.
Interleukin-2 histamine combination inhibit tumour growth angiogenesis malignant glioma.
Interleukin-2 human seminal plasma.
Interleukin-2 increased natural killer activity mice artificially infested Aspergillus niger.
Interleukin-2 interferon alpha 2 combination - Ineffectiveness single six-week patients metastatic renal cancer pretreated interferon.
Interleukin-2 interferon-alpha-2a outpatient therapy metastatic renal cell carcinoma.
Interleukin-2 interferon-fusion protein expression plasmid enhanced potency HBV DNA vaccination HBV transgenic mice.
Interleukin-2 interferon-gamma double knockout mice reject heterotopic cardiac allografts.
Interleukin-2 interferon-gamma production peripheral blood lymphocytes patients usual variable immunoinsufficiency.
Interleukin-2 interleukin-2 receptor expression human corticotrophic adenoma murine pituitary cell cultures.
Interleukin-2 interleukin-4 display potent antitumour activity rat medullary thyroid carcinoma cells.
Interleukin-2 and interleukin-4 increase the survival of retinal ganglion cells in culture.
Interleukin-2 interleukin-6 schizophrenia mania - Influences neuroleptics mood stabilizers.
Interleukin-2 effects the nervous scheme.
Interleukin-2 leukemia.
Interleukin-2 loss immunity experimental Mycobacterium avium infection.
Interleukin-2 lymphocyte-induced eosinophil proliferation survival asthmatic patients.
Interleukin-2 ovarian hyperstimulation syndrome. pilot study.
Interleukin-2 phytohaemagglutinin induce proliferation tunicate cells.
Interleukin-2 soluble interleukin-2 receptor bronchoalveolar lavage fluid patients bronchial asthma.
Interleukin-2 soluble interleukin-2 receptor levels children active pulmonary tuberculosis atypical mycobacterial adenitis.
Interleukin-2 systemic lupus erythematosus - Fifteen years.
Interleukin-2 modulator 5-fluorouracil hepatic arterial immunochemotherapy liver metastases.
Interleukin-2 neurotrophic factor supporting survival neurons cultured regions fetal rat brain.
Interleukin-2 adjuvant vaccination.
Interleukin-2 linear IgA bullous dermatosis.
Interleukin-2 augmented activation tumor macrophage plays main function MHC class I vivo induction tumor cells MHC negative vitro.
Interleukin-2 based home therapy advanced renal cell cancer (ARCC).
Interleukin-2 based home therapy metastatic renal cell carcinoma - Risks benefits 215 consecutive single institution patients.
Interleukin-2 based immunotherapy metastatic renal cell carcinoma kidney place.
Interleukin-2 based immunotherapy patients metastatic renal cell carcinoma.
Interleukin-2 and/or autologous bone marrow transplantation pediatric acute leukemia patients.
Interleukin-2 binds ganglioside GD1b.
Interleukin-2 blocks antitumour activity attributable depletion CD25+ cells murine renal adenocarcinoma model.
Interleukin-2 basic fibroblast growth factor elevated parkinsonian brain.
Interleukin-2 decreases accumbal dopamine efflux responding rewarding lateral hypothalamic stimulation.
Interleukin-2 deficit hemodialysis patients - Role prostaglandins.
Interleukin-2 dependent selective activation porcine gamma delta T lymphocytes extract leaves Acanthospermum hispidum.
Interleukin-2 dependent selective activation porcine gammadelta T lymphocytes extract leaves Acanthospermum hispidum.
Interleukin-2 diphtheria fusion protein (DAB-486IL-2) refractory rheumatoid arthritis.
Interleukin-2 enhances natural killer cell F-actin reorganization Wiskoff-Aldrich Syndrome in-vitro model.
Interleukin-2 induces activation proliferation chicken T cells vivo.
Interleukin-2 cross blood-brain barrier saturable transport scheme.
Interleukin-2 overcome suppression graft rejection cyclosporin A - Influence cyclosporin A T cell properties vivo.
Interleukin-2 sequester activated lymphocytes lung lymph sheep.
Interleukin-2 down-modulates memory T helper lymphocyte progress antigenic stimulation vitro.
Interleukin-2 driven nuclear translocation prolactin cloned T-lymphocytes.
Interleukin-2 influence apoptosis role human lymphocytes in vitro cytostatics culture.
Interleukin-2 enhances scopolamine-induced amnesia hyperactivity mouse.
Interleukin-2 enhances vulnerability colon cancer cells FasR-mediated apoptosis up-regulating Fas receptor degree down-regulating FAP-1 expression.
Interleukin-2 enhances growth human melanoma cells derived primary metastatic tumours.
Interleukin-2 enhances natural killer cell answer Herceptin-coated Her2/neu-positive breast cancer cells.
Interleukin-2 enhances production tumor necrosis factor-alpha activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Interleukin-2 enhances release endothelin-1 rat mesenteric artery.
Interleukin-2 enhances viability primary cultured rat neocortical neurons.
Interleukin-2 expanded lymphocytes lymph node tumor biopsies human renal cell carcinoma, breast ovarian cancer.
Interleukin-2 expanded tumor-infiltrating lymphocytes answer preoperative alpha-interferon patients renal cell carcinoma.
Interleukin-2 expression subpopulation primary T cells linked enhanced memory/effector role.
Interleukin-2 expression human carcinoma cell lines function cell cycle progression.
Interleukin-2 family cytokines induce phosphorylation Pro-Ser-Pro motif Stat5 transcription factors human T cells - Resistance suppression multiple serine kinase pathways.
Interleukin-2 cure human immunoinsufficiency virus infection.
Interleukin-2 cure solid tumors melanoma renal cell carcinoma.
Interleukin-2 fusion protein anti-CD3 single-chain Fv (sFv) selectively protects T cells dexamethasone-induced apoptosis.
Interleukin-2 fusion protein - An investigational therapy interleukin-2 receptor expressing malignancies.
Interleukin-2 gene deletion produces robust reduction vulnerability experimental autoimmune encephalomyelitis C57BL/6 mice.
Interleukin-2 gene expression biological prognostic marker hepatocellular carcinomas.
Interleukin-2 gene has superior antinociceptive effects when delivered intrathecally.
Interleukin-2 gene polymorphism renal cardiac transplant outcome.
Interleukin-2 gene polymorphisms increased risk gastric atrophy Helicobacter pylori infection.
Interleukin-2 gene therapy patient glioblastoma.
Interleukin-2 gene therapy chronic neuropathic pain.
Interleukin-2 gene therapy surgical minimal residual tumour disease.
Interleukin-2 gene transfer human transitional cell carcinoma urinary bladder.
Interleukin-2 gene transfer murine neuroblastoma decreases tumorigenicity enhances systemic immunity causing regression preestablished retroperitoneal tumors.
Interleukin-2 gene variation impairs regulatory T cell role autoimmunity.
Interleukin-2 gene-modified allogeneic melanoma cell vaccines stimulate cross-protection syngeneic tumors mice.
Interleukin-2 gene-modified allogeneic tumor cells cure relapsed neuroblastoma.
Interleukin-2 gene-transduced human leukemic cells stimulate major histocompatibility complex-restricted -unrestricted anti-leukemic effectors mixed lymphocyte-tumor cultures.
Interleukin-2 immunotherapy AIDS-related cytomegalovirus retinitis.
Interleukin-2 immunotherapy exerts differential influence CD4 CD8 T cell dynamics.
Interleukin-2 immunotherapy murine cytomegalovirus retinitis maids correlates increased intraocular CD8+ T-cell infiltration.
Interleukin-2 improves tumour answer DNP-modified autologous vaccine cure metastatic malignant melanoma.
Interleukin-2 combination interferon-alpha 5-fluorouracil metastatic renal cell cancer.
Interleukin-2 combination zidovudine didanosine maintain high levels CD4 cells undetectable HIV viraemia.
Interleukin-2 combined detoxifying therapy surgical sepsis.
Interleukin-2 human amniotic fluid pregnancy parturition - Implications prostaglandin E2 release fetal membranes.
Interleukin-2 human milk. potential modulator lymphocyte progress breastfed infant.
Interleukin-2 in human milk: a potential modulator of lymphocyte development in the breastfed infant
Interleukin-2 neuroblastoma - Clinical perspectives based biological investigations.
Interleukin-2 relationship T cell subpopulations rheumatic heart disease.
Interleukin-2 seminal plasma fertile infertile men.
Interleukin-2 in the pathogenesis of perinatal white matter damage.
Interleukin-2 cure haematological malignancies.
Interleukin-2 increases CD4+ lymphocyte numbers enhance responses immunization - Results A5046s.
Interleukin-2 increases choline acetyltransferase activity septal-cell cultures.
Interleukin-2 increases transcapillary diffusion sodium fluorescein human skin.
Interleukin-2 stimulated endothelium-dependent relaxation rat thoracic aorta.
Interleukin-2 stimulated immune effects human immunoinsufficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy.
Interleukin-2 induces N-glycosylation T-cells - Characterization human lymphocyte oligosaccharyltransferase.
Interleukin-2 induces fast increase ornithine decarboxylase mRNA cloned murine T lymphocytic cell line.
Interleukin-2 induces activation coagulation fibrinolysis - Resemblance experimental endotoxaemia.
Interleukin-2 induces early step activation interferon-gamma gene expression.
Interleukin-2 induces apoptosis mouse thymocytes.
Interleukin-2 induces cell cycle perturbations leading cell growth inhibition death malignant mesothelioma cells vitro.
Interleukin-2 induces progress dendritic cells cord blood CD34+ cells.
Interleukin-2 induces increased platelet-endothelium interactions. potential mechanism toxicity.
Interleukin-2 induces growth human glioblastoma cells culture.
Interleukin-2 induces proliferation mouse primordial germ cells vitro.
Interleukin-2 induces tyrosine phosphorylation nuclear translocation stat3 human T lymphocytes.
Interleukin-2 induces tyrosine phosphorylation SHP-2 IL-2 receptor beta-chain.
Interleukin-2 inhibited contractility extracted ventricular myocytes cardiac kappa-opioid receptor pathway.
Interleukin-2 inhibits 3T3 fibroblast proliferation.
Interleukin-2 inhibits HIV-1 replication in human macrophages by modulating expression of CD4 and CC-chemokine receptor-5.
Interleukin-2 inhibits NMDA receptor-mediated currents differentially affect subtypes.
Interleukin-2 inhibits eosinophil migration counteracted IL-5 priming.
Interleukin-2 inhibits proliferation HPV-associated tumor cells halts tumor growth vivo.
Interleukin-2 inhibits GABA-induced chlorine current identified Aplysia neurons.
Interleukin-2 inhibits replication human herpesvirus-6 mature thymocytes.
Interleukin-2 essential CD4+CD25+ regulatory T cell role.
Interleukin-2 synovium psoriatic arthritis spondyloarthritis, rheumatoid arthritis.
Interleukin-2 indispensable progress immunological self-tolerance.
Interleukin-2 killer cells - In vitro assessment combination prothymosin alpha.
Interleukin-2 degree mice infested Toxoplasma gondii.
Interleukin-2 levels carotid artery intima-media thickness.
Interleukin-2 levels chronic schizophrenia patients.
Interleukin-2 liposome inhalation therapy safe effective dogs spontaneous pulmonary metastases.
Interleukin-2 liposomes primary immune insufficiency aerosol.
Interleukin-2 mastering regulation cancer autoimmunity.
Interleukin-2 enhance inhibit antibody production B cells depending intracellular cAMP concentrations.
Interleukin-2 modulates N-methyl-D-aspartate receptors native mesolimbic neurons.
Interleukin-2 modulates calcium currents dissociated hippocampal CA1 neurons.
Interleukin-2 modulates evoked release (tritiated) dopamine rat cultured mesencephalic cells.
Interleukin-2 modulates responsiveness angiotensin II cultured vascular smooth muscle cells.
Interleukin-2 mutants enhanced alpha-receptor subunit binding affinity.
Interleukin-2 chemotherapy patients metastatic melanoma.
Interleukin-2 potentiates foot-and-mouth disease vaccinal immune responses mice.
Interleukin-2 potentiates novelty- GBR 12909-induced exploratory activity.
Interleukin-2 potentiation cetuximab antitumor activity epidermal growth factor receptor-overexpressing gastric cancer xenografts antibody-dependent cellular cytotoxicity.
Interleukin-2 prevention apoptosis human neutrophils.
Interleukin-2 prevents programmed cell death adult T-cell leukemia cells.
Interleukin-2 prevents programmed cell death chronic lymphocytic leukemia cells.
Interleukin-2 primes eosinophil degranulation hypereosinophilia Wells syndrome.
Interleukin-2 production alteration T cell subsets mice infested Naegleria fowleri.
Interleukin-2 production expression interleukin-2 receptor activated peripheral blood T-lymphocytes Hodgkin's disease.
Interleukin-2 production answer exogenous interleukin-2 patient acquired immune insufficiency syndrome (AIDS).
Interleukin-2 production T cells. study immunoregulatory actions interferon-alpha, interferon-gamma, tumor necrosis factor-alpha phenotypically diverse T cell clones.
Interleukin-2 production human leukemia cell lines pre-B cell origin.
Interleukin-2 production mitogen-stimulated intestinal mucosal leukocytes cattle.
Interleukin-2 production peripheral blood mononuclear cells patients myasthenia gravis.
Interleukin-2 production primary adult T cell leukemia tumor cells macrophage dependent.
Interleukin-2 production SC TK chickens infested Eimeria tenella.
Interleukin-2 production pediatric inflammatory bowel disease - Proof dissimilar mononuclear cell role Crohn's disease ulcerative colitis.
Interleukin-2 production vitro. advance study rabies vaccine immunogenicity appraised testing diverse glycoprotein presentations.
Interleukin-2 production blood cell cultures women undergoing controlled ovarian hyperstimulation assisted reproduction technology cycles.
Interleukin-2 production altered copper insufficiency.
Interleukin-2 production suppressed dietary N-3 fatty acids enhanced oral aspirin.
Interleukin-2 production lymphocytes food sensitive atopic dermatitis.
Interleukin-2 promoter activity Epstein-Barr virus-transformed B lymphocytes controlled nuclear factor-kappa-B.
Interleukin-2 promotes angiogenesis activation Akt increase ROS.
Interleukin-2 promotes antigenic reactivity rested T cells prolongs postactivational refractory phase activated T cells.
Interleukin-2 promotes survival neurite extension cultured neurons fetal rat brain.
Interleukin-2 promotes motility dendritic cells accumulation lung skin.
Interleukin-2 protects endothelial dysfunction stimulated high glucose levels rats.
Interleukin-2 racemic lymphocytes consolidative immunotherapy autologous bone marrow transplantation hematologic malignancies.
Interleukin-2 receptor (CD25) upregulation human T-lymphocytes - Sensitivity immunosuppressants defined mode T-lymphocyte activation.
Interleukin-2 receptor alpha chain acute myelocytic leukemia cells involved cell-to-cell interactions.
Interleukin-2 receptor alpha(p55) mRNA expression alveolar lymphocytes patients sarcoidosis.
Interleukin-2 receptor beta-2 microglobulin levels measure monitoring renal allograft recipients.
Interleukin-2 receptor ovarian cancer.
Interleukin-2 receptor antibody-induced alterations ciclosporin dose demands paediatric transplant recipients.
Interleukin-2 receptor chain - molecular cloning functional expression human cDNA.
Interleukin-2 receptor beta gamma chain dysregulation inhibition CD4 T cell activation human immunoinsufficiency virus-1 gp120.
Interleukin-2 receptor beta chain potential target doses mafosfamide.
Interleukin-2 receptor beta chain locus rearrangement T-cell acute lymphoblastic leukemia.
Interleukin-2 receptor blockade cardiac transplantation - Effect HLA-DR locus incompatibility cure efficacy.
Interleukin-2 receptor chain mutation results X-linked severe combined immunoinsufficiency humans.
Interleukin-2 receptor usual gamma-chain signaling cytokines regulate activated T cell apoptosis answer growth factor withdrawal - Selective induction anti-apoptotic (bcl-2, bcl-x-L) pro-apoptotic (bax, bcl-x-s) gene expression.
Interleukin-2 receptor downstream events regulatory T cells: Implications choice immunosuppressive drug therapy.
Interleukin-2 receptor gamma chain mutation results X-linked severe combined immunoinsufficiency humans.
Interleukin-2 receptor gamma chain. functional constituent interleukin-4 receptor.
Interleukin-2 receptor gamma chain. functional constituent interleukin-7 receptor.
Interleukin-2 receptor peripheral lymphocytes primary retinitis pigmentosa.
Interleukin-2 receptor levels patients active pulmonary tuberculosis antituberculous chemotherapy.
Interleukin-2 receptor levels sera patients rheumatoid arthritis treated sulfasalazine, parenteral gold, placebo.
Interleukin-2 receptor levels sera rheumatoid arthritis patients treated methotrexate.
Interleukin-2 receptor signaling mechanisms.
Interleukin-2 receptor-c-dependent endocytosis depends biotin Jurkat cells.
Interleukin-2 receptor-gamma-dependent endocytosis depends biotin Jurkat cells.
Interleukin-2 receptor-specific fusion toxin inhibits barotrauma-induced arterial atherosclerosis.
Interleukin-2 receptoralpha gene expression intestinal allograft rejection.
Interleukin-2 receptors interleukin-2-mediated signaling myelin - Activation diacylglycerol kinase phosphatidylinositol 3-kinase.
Interleukin-2 receptors experimental Chagas disease.
Interleukin-2 reconstitutes defective human immunoinsufficiency virus (HIV), cytomegalovirus (CMV) special CD8+ T cell proliferation HIV infection.
Interleukin-2 regulates membrane potentials calcium channels mu opioid receptors rat dorsal root ganglion neurons.
Interleukin-2 regulates monoamine opioid peptide release hypothalamus.
Interleukin-2 regulates activity ornithine decarboxylase cloned murine T lymphocytic cell line - proof protein kinase C-dependent pathway.
Interleukin-2 restores natural killer activity inhibited sera HIV+ hemophilic patients.
Interleukin-2 reverses T cell unresponsiveness Plasmodium falciparum-antigen malaria immune subjects.
Interleukin-2 reverses defect activation-induced apoptosis T cells autoimmune Ipr mice.
Interleukin-2 secreting cells multiple sclerosis controls.
Interleukin-2 secretion human B lymphocytes occurs late event requires stimulation CD40 cross-linking.
Interleukin-2 secretion mammary gland mononuclear cells nonlactating period.
Interleukin-2 secretion transduced unselected BDL-2 lymphoma results increased survival mice previously established disseminated disease.
Interleukin-2 signal transduction human NK cells - Multisite phosphorylation activation tyrosine kinase p56-lck.
Interleukin-2 signaling STAT5 constrains T helper 17 cell generation.
Interleukin-2 signals priming required secondary expansion CD8(+) memory T cells.
Interleukin-2 signals priming required secondary expansion CD8+ memory T cells.
Interleukin-2 soluble receptor malignant hemopathies.
Interleukin-2 stimulates late increase phosphatidic acid production absence phospholipase D activation.
Interleukin-2 stimulates cell proliferation growth hormone producing human pituitary adenoma vitro.
Interleukin-2 stimulates proliferation cultured RC-4B/C pituitary adenoma cell line.
Interleukin-2 stimulates secretion arginine vasopressin corticotropin-releasing hormone rat hypothalamic cells vitro.
Interleukin-2 suppresses activated macrophage intracellular killing activity inducing macrophages secrete TGF-beta.
Interleukin-2 suppression 2-arachidonyl glycerol mediated peroxisome proliferator-activated receptor gamma independently cannabinoid receptors 1 2.
Interleukin-2 suppression cats naturally infested feline leukemia virus.
Interleukin-2 therapy allogeneic bone marrow transplantation acute myelocytic leukemia - Investigations relevant rat model AML.
Interleukin-2 therapy does not exacerbate multiple sclerosis.
Interleukin-2 therapy advanced chronic myeloid leukemia.
Interleukin-2 therapy HIV infection.
Interleukin-2 therapy Langerhans cell histiocytosis.
Interleukin-2 therapy cancer.
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses primary infection subjects receiving HAART.
Interleukin-2 therapy reverses immunosuppressive effects skeletal unloading.
Interleukin-2 transcriptional block multifunctional Ca-2+/calmodulin kinase.
Interleukin-2 transcripts human rodent brains - Possible expression astrocytes.
Interleukin-2 transfected prostate cancer cells generate local antitumor influence vivo.
Interleukin-2 treatment of microglia has no effect on in vitro HIV infection.
Interleukin-2 up-regulates expression human immunoinsufficiency virus fusion coreceptor CCR5 CD4+ lymphocytes vivo.
Interleukin-2 lymphokine-activated killer cells consolidative immunotherapy autologous bone marrow transplantation acute myelogenous leukemia.
Interleukin-2, Interleukin-15, Their Roles Human Natural Killer Cells.
Interleukin-2, interleukin-15, required terminate artificially stimulated clonal T-cell anergy.
Interleukin-2, interferon-alpha interleukin-2 interferon-alpha renal cell carcinoma - randomized phase II experiment.
Interleukin-2, interferon-alpha medroxyprogesterone acetate metastatic renal cell carcinoma.
Interleukin-2, interferon-alpha, 5-fluorouracil, vinblastine cure metastatic renal cell carcinoma. prospective Phase II study - The experience Rambam Lin Medical Centers 1996-2000.
Interleukin-2, interferon-gamma natural killer cell activity bronchoalveolar lavage fluid marrow transplant recipients cytomegalovirus pneumonia.
Interleukin-2, interleukin-12, interferon-gamma levels risk young adult Hodgkin lymphoma.
Interleukin-2, receptor nutrition older adults. review.
Interleukin-2, melatonin interleukin-12 potential neuroimmune combination biotherapy cancer.
Interleukin-2- interferon-gamma-secreting T cells normal diseased human intestinal mucosa.
Interleukin-2-activated hematopoietic stem cell transplantation breast cancer - Study dose degree medical correlates.
Interleukin-2-activated human effector lymphocytes mediate cytotoxicity inducing apoptosis human leukaemia solid tumour target cells.
Interleukin-2-activated natural killer cells stimulate apoptosis necrosis rat hepatocytes.
Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy.
Interleukin-2-based biochemotherapy patients stage IV melanoma - Long-term survivors medical experiment setting.
Interleukin-2-collagen chimeric protein liberates interleukin-2 collagenolysis.
Interleukin-2-dependent augmentation anti-TNP antibody production sodium butyrate cultured murine splenic B cells.
Interleukin-2-dependent mechanisms involved progress glomerulosclerosis partial renal ablation rats.
Interleukin-2-dependent regulation Na/K pump human lymphocytes.
Interleukin-2-independent proliferation human melanoma-reactive T lymphocytes transduced exogenous IL-2 gene stimulation dependent.
Interleukin-2-induced antinociception morphine-insensitive rats.
Interleukin-2-induced behavioural, neurotransmitter, immunological parameters olfactory bulbectomized rat.
Interleukin-2-induced hepatic injury involves temporal patterns cell adhesion microcirculation.